Literature DB >> 738764

Cellular requirements for the formation of EA rosettes by human monocytes.

J H Passwell, E Schneeberger, E Merler.   

Abstract

The binding of sensitized red cells to Fc receptors in human monocytes was studied by evaluating the effects of various pharmacological reagents and other treatments on EA rosette formation. Cytochalasin B and 2-deoxyglucose inhibited rosette formation in a dose-dependent manner. Sodium azide and incubation at 4 degrees also inhibited rosette formation, while at 37 degrees increased numbers of RBCs bound to the monocytes. The microtubular poisons, vinblastine and colchicine at high concentrations resulted in decreased adherence of monocytes and inhibition of rosette formation, while at low concentrations of colchicine, enhanced rosette formation was sometimes observed. Contrary to the effects on rosette formation, binding of [125I] IgG to monocyte monolayers was not altered by treatment of the monocytes with drugs. Magnesium ions were required to promote monocyte adherence, but both magnesium and calcium were needed for the best rosette formation. We conclude that the formation of EA rosettes is dependent not merely on binding of IgG to the Fc receptor but requires metabolically active monocytes, an intact cytostructure and suitable environmental conditions (temperature and cation concentration).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 738764      PMCID: PMC1457450     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Structural units of human 7S gamma globulin.

Authors:  E C FRANKLIN
Journal:  J Clin Invest       Date:  1960-12       Impact factor: 14.808

2.  Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro.

Authors:  J Rhodes
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

3.  Modulation of macrophage Fc receptor function by cytochalasin-sensitive structures.

Authors:  J P Atkinson; C W Parker
Journal:  Cell Immunol       Date:  1977-10       Impact factor: 4.868

4.  Cytochalasin B. IV. Inhibition and stimulation of chemotaxis of rabbit and human polymorphonuclear leukocytes.

Authors:  E L Becker; A T Davis; R D Estensen; P G Quie
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

5.  Disappearance and recovery of human monocyte IgG receptor activity after phagocytosis.

Authors:  M E Schmidt; S D Douglas
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

6.  Effect of cytochalasin B on human monocyte binding and sphering of IgG-coated human erythrocytes.

Authors:  B Herskovitz; D Guerry; R A Cooper; A D Schreiber
Journal:  Blood       Date:  1977-02       Impact factor: 22.113

7.  Regulation of lymphocyte responses in vitro: potentiation and inhibition of rat lymphocyte responses to antigen and mitogens by cytochalasin B.

Authors:  M Yoshinaga; A Yoshinaga; B H Waksman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

8.  Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man.

Authors:  A F LoBuglio; R S Cotran; J H Jandl
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

9.  Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures.

Authors:  J P Atkinson; J M Michael; H Chaplin; C W Parker
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

10.  2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages. I. Description of the inhibitory effect.

Authors:  J Michl; D J Ohlbaum; S C Silverstein
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

View more
  12 in total

1.  Activation of human monocytes via their sIgA receptors.

Authors:  S Padeh; C L Jaffe; J H Passwell
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

Review 2.  The immunosuppressive effects of bilirubin.

Authors:  V Vĕtvicka; P Síma; I Miler; M Bilej
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

3.  Fc receptors of rat peritoneal macrophages: immunoglobulin class specificity and sensitivity to drugs affecting the microfilament or microtubule system.

Authors:  G A Medgyesi; G Fóris; B Dezsö; J Gergely; H Bazin
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

4.  Transient cyclic AMP accumulation during antibody-dependent cytotoxicity mediated by monocytes and neutrophils.

Authors:  T Herlin; K Kragballe
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

5.  Effects of concanavalin A and Fc fragments of IgG on human monocyte cAMP content: modulation of monocyte secretory function by cAMP.

Authors:  J H Passwell; S R Goldring; J M Dayer
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

6.  The effect of bilirubin on the Fc receptor expression and phagocytic activity of mouse peritoneal macrophages.

Authors:  V Vĕtvicka; I Miler; P Síma; L Táborský; L Fornůsek
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

7.  Which Fc receptor-bearing cells are detected with the Ripley assay?

Authors:  T R Andersson; J L Svennevig
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

8.  Comparison of the effect of various stimuli on the leishmaniacidal capacity of human monocytes in vitro.

Authors:  J Passwell; R Shor; G Keren; G Messer; J El-On
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  Colchicine in generalized pustular psoriasis: clinical response and antibody-dependent cytotoxicity by monocytes and neutrophils.

Authors:  H Zachariae; K Kragballe; T Herlin
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

10.  Modulation of human monocyte functions by Fc fragments of IgG: a comparison to other monocyte 'activators'.

Authors:  J H Passwell; H R Colten; E L Schneeberger; Z Marom; E Merler
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.